Skip to main content
Professional Technical IVT

panretinal photocoagulation

Pronunciation: pan-RET-ih-nal foh-toh-koh-AG-yoo-LAY-shun

Laser treatment applied to the peripheral retina to reduce abnormal blood vessel growth in diabetic retinopathy.

Full Definition

Panretinal photocoagulation (PRP) is a laser therapy technique used primarily to treat proliferative diabetic retinopathy and other ischemic retinal conditions. The procedure involves applying 1,200-1,600 laser burns to the peripheral retina, deliberately destroying ischemic tissue to reduce the production of angiogenic factors. This helps prevent further neovascularization and reduces the risk of vitreous hemorrhage and retinal detachment. Treatment is typically performed in multiple sessions to minimize patient discomfort and reduce complications.

Usage

Usage note: Commonly abbreviated as PRP; distinguish from focal laser treatments which target specific lesions.

In Context

  • "Panretinal photocoagulation was completed in three sessions to treat high-risk proliferative diabetic retinopathy." — Treatment progress note
  • "PRP successfully caused regression of neovascularization within six weeks of treatment completion." — Follow-up examination report

Also known as

PRP scatter laser photocoagulation

Contrasted with

focal laser treatment

Don't confuse with

focal photocoagulation grid photocoagulation

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON